ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
High dose chemotherapy and autologous blood stem cell support in women with breast carcinoma and isolated supraclavicular lymph node metastases
Cancer
◽
10.1002/(sici)1097-0142(20000215)88:4<790::aid-cncr9>3.0.co;2-m
◽
2000
◽
Vol 88
(4)
◽
pp. 790-795
◽
Cited By ~ 16
Author(s):
Rick Abraham
◽
Tracy Nagy
◽
Paul E. Goss
◽
Michael Crump
Keyword(s):
Stem Cell
◽
Lymph Node
◽
Breast Carcinoma
◽
Autologous Blood
◽
High Dose Chemotherapy
◽
High Dose
◽
Supraclavicular Lymph Node
◽
Stem Cell Support
◽
Node Metastases
◽
Cell Support
Download Full-text
Related Documents
Cited By
References
Randomized trial of high-dose chemotherapy and autologous hematopoietic stem cell support for high-risk primary breast carcinoma
Cancer
◽
10.1002/cncr.21906
◽
2006
◽
Vol 106
(11)
◽
pp. 2327-2336
◽
Cited By ~ 23
Author(s):
Emer O. Hanrahan
◽
Kristine Broglio
◽
Deborah Frye
◽
Aman U. Buzdar
◽
Richard L. Theriault
◽
...
Keyword(s):
Stem Cell
◽
High Risk
◽
Breast Carcinoma
◽
Randomized Trial
◽
High Dose Chemotherapy
◽
High Dose
◽
Primary Breast Carcinoma
◽
Hematopoietic Stem
◽
Stem Cell Support
◽
Cell Support
Download Full-text
Expression of C-erbB-2/HER-2 in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous blood stem cell support
Bone Marrow Transplantation
◽
10.1038/sj.bmt.1701907
◽
1999
◽
Vol 24
(4)
◽
pp. 377-384
◽
Cited By ~ 19
Author(s):
M Bewick
◽
T Chadderton
◽
M Conlon
◽
R Lafrenie
◽
D Morris
◽
...
Keyword(s):
Breast Cancer
◽
Stem Cell
◽
Metastatic Breast Cancer
◽
Autologous Blood
◽
Metastatic Breast
◽
High Dose Chemotherapy
◽
High Dose
◽
Stem Cell Support
◽
Her 2
◽
Cell Support
Download Full-text
Twelve-year follow-up of a randomized trial of high-dose chemotherapy (HDC) and autologous hematopoietic stem cell support (ASCS) for high-risk primary breast carcinoma
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.663
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 663-663
◽
Cited By ~ 1
Author(s):
E. O. Hanrahan
◽
D. Frye
◽
A. U. Buzdar
◽
R. L. Theriault
◽
D. J. Booser
◽
...
Keyword(s):
Stem Cell
◽
High Risk
◽
Breast Carcinoma
◽
High Dose Chemotherapy
◽
High Dose
◽
Primary Breast Carcinoma
◽
Hematopoietic Stem
◽
Stem Cell Support
◽
Cell Support
Download Full-text
P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support
International Journal of Cancer
◽
10.1002/ijc.10478
◽
2002
◽
Vol 100
(3)
◽
pp. 290-296
◽
Cited By ~ 20
Author(s):
Manfred Hensel
◽
Andreas Schneeweiss
◽
Hans-Peter Sinn
◽
Gerlinde Egerer
◽
Erich Solomayer
◽
...
Keyword(s):
Breast Cancer
◽
Stem Cell
◽
High Risk
◽
Cancer Patients
◽
Autologous Blood
◽
High Dose Chemotherapy
◽
High Dose
◽
Breast Cancer Patients
◽
Stem Cell Support
◽
Cell Support
Download Full-text
Stem Cell Dose and Tumorbiologic Parameters as Prognostic Markers for Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy with Autologous Blood Stem Cell Support
Stem Cells
◽
10.1634/stemcells.20-1-32
◽
2002
◽
Vol 20
(1)
◽
pp. 32-40
◽
Cited By ~ 7
Author(s):
Manfred Hensel
◽
Andreas Schneeweiss
◽
Hans-Peter Sinn
◽
Gerlinde Egerer
◽
Martin Kornacker
◽
...
Keyword(s):
Breast Cancer
◽
Stem Cell
◽
Metastatic Breast Cancer
◽
Prognostic Markers
◽
Autologous Blood
◽
Metastatic Breast
◽
High Dose Chemotherapy
◽
High Dose
◽
Stem Cell Support
◽
Cell Support
Download Full-text
94 P - Paclitaxel containing high-dose chemotherapy and autologous blood stem cell support for high risk primary breast cancer
European Journal of Cancer
◽
10.1016/0959-8049(96)84848-9
◽
1996
◽
Vol 32
◽
pp. S19
Author(s):
H.T. Greinix
◽
W. Linkeach
◽
M. Seifert
◽
E. Kubista
◽
K. Czerwendka
◽
...
Keyword(s):
Breast Cancer
◽
Stem Cell
◽
High Risk
◽
Primary Breast Cancer
◽
Autologous Blood
◽
High Dose Chemotherapy
◽
Blood Stem Cell
◽
High Dose
◽
Stem Cell Support
◽
Cell Support
Download Full-text
Expression of C-Erb B-2/Her-2 in Patients with Metastatic Breast Cancer Undergoing High-Dose Chemotherapy and Autologous Blood Stem Cell Support
Molecular Biology of Hematopoiesis 6
◽
10.1007/978-1-4615-4797-6_12
◽
1999
◽
pp. 91-102
Author(s):
M. Bewick
◽
T. Chadderton
◽
M. Conlon
◽
R. Lafrenie
◽
Stefan Glück
Keyword(s):
Breast Cancer
◽
Stem Cell
◽
Metastatic Breast Cancer
◽
Autologous Blood
◽
Metastatic Breast
◽
High Dose Chemotherapy
◽
High Dose
◽
Stem Cell Support
◽
Her 2
◽
Cell Support
Download Full-text
Acute Pseudo-Obstruction of the Small Intestine Following High-Dose Chemotherapy and Stem Cell Support
Oncology Research and Treatment
◽
10.1159/000072093
◽
2003
◽
Vol 26
(4)
◽
pp. 344-346
◽
Cited By ~ 1
Author(s):
T. Bauernhofer
◽
M. Eibl
◽
F. Ploner
◽
I. Kuss
◽
J. Pfeifer
◽
...
Keyword(s):
Small Intestine
◽
Stem Cell
◽
High Dose Chemotherapy
◽
High Dose
◽
Stem Cell Support
◽
Cell Support
Download Full-text
High-dose chemotherapy and stem-cell support in breast cancer
The Lancet
◽
10.1016/s0140-6736(98)00036-1
◽
1998
◽
Vol 352
(9135)
◽
pp. 1220
Author(s):
Paolo Pedrazzoli
◽
Gian Antonio Da Prada
◽
Gioacchino Robustelli della Cuna
Keyword(s):
Breast Cancer
◽
Stem Cell
◽
High Dose Chemotherapy
◽
High Dose
◽
Stem Cell Support
◽
Cell Support
Download Full-text
High-dose chemotherapy using BEAM for tumor debulking without stem cell support followed by early allogeneic reduced intensity conditioning transplantation to induce a graft-versus-lymphoma effect in patients with high risk or refractory lymphoma
Bone Marrow Transplantation
◽
10.1038/sj.bmt.1704489
◽
2004
◽
Vol 33
(10)
◽
pp. 1011-1014
◽
Cited By ~ 9
Author(s):
A S Buser
◽
D Heim
◽
C Bucher
◽
A Tichelli
◽
A Gratwohl
◽
...
Keyword(s):
Stem Cell
◽
High Risk
◽
High Dose Chemotherapy
◽
High Dose
◽
Reduced Intensity Conditioning
◽
Stem Cell Support
◽
Refractory Lymphoma
◽
Tumor Debulking
◽
Cell Support
◽
Reduced Intensity
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close